123Tom's TA study group

[MinnieM]

Sorry to have missed your question... in answer, I added to my ctix position this morning.

Prurisol ph2b should give interim results sooner than most people expect. The ph2 trial completed earlier than projection. The current trial is scheduled to complete in June. With 25 sites recruiting 189 patients I'd guess we get interim results any time now. The ph2 had 9 sites for 115 patients. The ph2 had 4 arms and showed efficacy in the highest dosage of 200mg. The two arms with lower dosages did no better than the placebo. The ph2b has 3 arms. placebo n=81, 300mg n=81 and 400mg n=27.

https://clinicaltrials.gov/ct2/show/NCT02949388?term=cellceutix&rank=5&flds=abcefgps&submit_fld_opt=

We'll find out soon how this one does with the higher dosages. I'm surprised they don't have a 200mg arm again, but, the company must expect the 300mg arm to do well.







In Reply to '123tom'
youre very welcome Karin

did you reply to my question about CTIX ? I was wondering your thoughts and whether you still considered CTIX an worthy investment to get back into around the 1 dollar base. its been in such a down turn here for a while now.
I sold it a few months ago before the final collapse. but it sits at 1 dollar area and I would value your outlook. Thanks again.

T